Laura Catena Selected Research

Neoplasms (Cancer)

3/2018	Sunitinib in patients with pre-treated pancreatic neuroendocrine tumors: A real-world study.
1/2018	Metformin Use Is Associated With Longer Progression-Free Survival of Patients With Diabetes and Pancreatic Neuroendocrine Tumors Receiving Everolimus and/or Somatostatin Analogues.
1/2018	Everolimus in Combination with Octreotide Long-Acting Repeatable in a First-Line Setting for Patients with Neuroendocrine Tumors: A 5-Year Update.
9/2011	Neuroendocrine tumors of unknown primary site: gold dust or misdiagnosed neoplasms?
7/2010	Common Diagnostic Challenges in the Histopathologic Diagnosis of Neuroendocrine Lung Tumors: A Case Report.
1/2009	The impact of antithrombotic prophylaxis on infectious complications in cancer patients with central venous catheters: an observational study.
11/2006	Lanreotide autogel every 6 weeks compared with Lanreotide microparticles every 3 weeks in patients with well differentiated neuroendocrine tumors: a Phase III Study.
11/2006	Kit protein (CD117) and proliferation index (Ki-67) evaluation in well and poorly differentiated neuroendocrine tumors.
1/2006	Neuroendocrine tumors of the larynx: a clinical report and literature review.
10/2003	Update on the treatment of neuroendocrine tumors.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Laura Catena Research Topics

Disease

12	Neoplasms (Cancer) 03/2018 - 01/2002
10	Neuroendocrine Tumors (Neuroendocrine Tumor) 03/2018 - 03/2003
4	Breast Neoplasms (Breast Cancer) 01/2019 - 01/2002
2	Carcinoma (Carcinomatosis) 06/2011 - 07/2010
2	Renal Cell Carcinoma (Grawitz Tumor) 03/2007 - 01/2007
1	Osteoporosis 01/2019
1	Dyslipidemias (Dyslipidemia) 01/2019
1	Hypertension (High Blood Pressure) 01/2019
1	Arthralgia (Joint Pain) 01/2019
1	Hyperglycemia 01/2018
1	Neoplasm Metastasis (Metastasis) 01/2018
1	Primitive Neuroectodermal Tumors (PNET) 01/2018
1	Triple Negative Breast Neoplasms 01/2018
1	Neuroendocrine Carcinoma 10/2014
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 07/2010
1	Carcinoid Tumor (Carcinoid) 07/2010
1	Hyperplasia 07/2009
1	Atrophic Gastritis 07/2009
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 07/2009
1	Sarcoidosis (Schaumann Disease) 07/2009
1	Catheter-Related Infections 01/2009
1	Infections 01/2009
1	Merkel Cell Carcinoma 05/2007
1	Disease Progression 01/2007
1	Nausea 01/2002
1	Diarrhea 01/2002
1	Abdominal Pain (Pain, Abdominal) 01/2002

Drug/Important Bio-Agent (IBA)

4	Octreotide (Sandostatin)FDA LinkGeneric 01/2018 - 01/2002
4	Everolimus FDA Link 01/2018 - 06/2011
4	Biological ProductsIBA 07/2010 - 03/2003
3	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2018 - 01/2002
2	lanreotide (Somatuline)FDA Link 01/2018 - 11/2006
2	Sorafenib (BAY 43-9006)FDA Link 03/2007 - 01/2007
1	Aromatase InhibitorsIBA 01/2019
1	Sunitinib (Sutent)FDA Link 03/2018
1	eribulin FDA Link 01/2018
1	Glucose (Dextrose)FDA LinkGeneric 01/2018
1	Hemoglobins (Hemoglobin)IBA 01/2018
1	Metformin (Glucophage)FDA LinkGeneric 01/2018
1	Drug CombinationsIBA 10/2014
1	Cisplatin (Platino)FDA LinkGeneric 10/2014
1	GoldIBA 09/2011
1	TOR Serine-Threonine KinasesIBA 06/2011
1	Estrogens (Estrogen)FDA Link 07/2009
1	AnticoagulantsIBA 01/2009
1	Tumor Biomarkers (Tumor Markers)IBA 11/2006
1	Proteins (Proteins, Gene)FDA Link 11/2006
1	Capecitabine (Xeloda)FDA Link 04/2005
1	Interferon-alpha (Interferon Alfa)IBA 10/2003
1	Insulin (Novolin)FDA Link 01/2002
1	Tamoxifen FDA LinkGeneric 01/2002
1	Somatostatin Receptors (Somatostatin Receptor)IBA 01/2002
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2002
1	thiamine triphosphorate (TTP)IBA 01/2002

Therapy/Procedure

5	Therapeutics 01/2019 - 01/2002
3	Biological Therapy 03/2007 - 03/2003
2	Drug Therapy (Chemotherapy) 10/2003 - 03/2003
1	Aftercare (After-Treatment) 01/2018
1	Central Venous Catheters 01/2009
1	Catheters 01/2009
1	Liver Transplantation 05/2007